BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. DNMT1, Response to oxidative stress, Leukemia, Lymphocyte, Laryngoscope, Vitamin E)
Bookmark Forward

QuickView for recombinant fviia (compound)


Genetic Markers

Most Correlated Genes

  1. F10
  2. F9
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. Peptidase S1A, coagulation factor VII/IX/X/C/Z
  2. REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS
  3. Coagulation factor-like, Gla domain superfamily
  4. Gamma-carboxyglutamic acid-rich (GLA) domain superfamily
  5. Gamma-carboxyglutamic acid-rich (GLA) domain
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug target sets for approved compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Off-label use of recombinant factor VIIa in two tertiary hospitals in Queensland.
  2. Thromboelastometry as an Ancillary Tool for Evaluation of Coagulation Status after rFVIIa Therapy in…
  3. Predicting response to rFVIIa in neonates with intractable bleeding or severe coagulation disturbanc…
  4. Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient.
  5. The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Phase III Study of Coagulation FVIIa (Recombinant) in Congenital Hemophilia A or B Patients With Inh…
  2. Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII
  3. A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Underg…
  4. Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or …
  5. Recombinant Activated Factor VII in the Management of Massive Bleeding in Hospital Universiti Sains …
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.